trademax42 Sunday, 08/02/20 09:09:24 AM Re: None Post # of 8442 Selling at $1 is short changing yourself, imo. CYD*Y went to $10 dollars on a phase 2 study and has 564M OS. RVVTF is on the path to a phase 3 study and has only 189M OS. In fact the FDA recommended this little gem RVVTF to proceed to phase 3 study. Both CYD*Y and RVVTF are investigating a COVID-19 therapeutic treatment/cure. You do the math where the PPS for RVVTF should be. $RVVTF Disclaimer: Just my opinion of course, do your own DD.